Viewing Study NCT05919693


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-01-07 @ 5:43 AM
Study NCT ID: NCT05919693
Status: COMPLETED
Last Update Posted: 2025-11-20
First Post: 2023-06-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)
Sponsor: EyeBiotech Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-06-12
Start Date Type: ACTUAL
Primary Completion Date: 2024-08-26
Primary Completion Date Type: ACTUAL
Completion Date: 2024-08-26
Completion Date Type: ACTUAL
First Submit Date: 2023-06-14
First Submit QC Date: None
Study First Post Date: 2023-06-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2023-12-07
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2025-11-18
Last Update Post Date: 2025-11-20
Last Update Post Date Type: ESTIMATED